Investing.com – Pfizer (NYSE: ) On Tuesday, the first quarter ended with revenue surpassing expectations. Analysts’ estimates were exceeded by the company.

Pfizer reported earnings per share at $1.62 for revenue of $24.1B. Investing.com polled analyst to predict EPS of $1.52 based on $24.1B revenue.

Pfizer shares fell 5% over the first of the year but are still below its 52-week peak of $61.71, which was set December 20, 2021. They are outperforming the S&P 500 which is down 12.82% from the start of the year.

Pfizer reports on other earnings in the healthcare sector.

Pfizer’s earnings beat was achieved by UnitedHealth, who on April 14 reported an EPS of $5.49 for revenue of $80.15B. This compares to the forecasts of EPS at $5.36 for revenue of $78.73B.

J&J had beat expectations on April 19 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.

You can keep up-to date on the latest earnings reports by visiting Investing.com’s earnings calendar